Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma

作者：Kaemmerer Peer W; Toyoshima Takeshi^*; Schoeder Fabian; Kaemmerer Philipp; Kuhr Kathrin; Brieger Juergen; Al Nawas Bilal

来源：Oral Oncology, 2010, 46(7): 543-548.

DOI：10.1016/j.oraloncology.2010.03.025

• Oral squamous cell carcinoma
• T-lymphocyte
• Polymorphism
• Costimulatory molecule
• CTLA-4
• CD28
• ICOS
• Case-control

Costimulatory molecules have complementary effects on T-cell activation and their balance may control the development of oral cancer. The aim of this study was to determine the relevance of cytotoxic T-lymphocyte antigen 4 (CTLA-4), CD28 and inducible costimulator (ICOS) polymorphisms in oral squamous cell carcinoma (OSCC).
Genotyping for CTLA-4 (-1661 A/G and + 49 A/G), CD28 (0 C/G and + 3160 G/T) and ICOS (+ 637 A/C and + 1599 C/T) was performed in the 83 patients with OSCC, compared to the 40 unrelated healthy volunteers as controls.
The genotype CTLA-4 -1661 was significantly different between the patient group and the control group. The allele CTLA-4 -1661 G was significantly found more frequent in patients with OSCC (p = 0.001). In bivariate analysis, noticeable differences between OSCC and controls were seen. The combinations CTLA-4 -1661 G/G and CTLA-4 + 49 A/G, ICOS + 1559 C/T and ICOS + 1559 C/C each with CTLA-4 -1661 G/G, ICOS + 637 C/C and ICOS + 637 A/C each with CTLA-4 -1661, CTLA-4 -1661 A/G and ICOS + 637 C/C, CD28 + 3160 G/T and CTLA-4 -1661 A/A and CD28 + 3160 G/T and CTLA-4 -1661 A/G were seen in the patient group only.
Especially the polymorphisms of the CTLA-4 -1661-genotype - alone and in combination with other T cell regulator polymorphisms - seem to be possible predisposing factors for OSCC. Therefore, they might be future targets for a primary prophylaxis or an individualised therapy.

• 出版日期2010-7
• 单位河北医科大学